Publications by authors named "Martha Bajwa-Joseph"
Article Synopsis
- - The study tested the neuroprotective effects of exenatide, a GLP-1 receptor agonist, in patients with moderate Parkinson's disease through a double-blind, placebo-controlled trial over 48 weeks.
- - A total of 62 patients were assigned to receive either exenatide or placebo, with outcomes measured primarily using the MDS-UPDRS motor subscale at 60 weeks.
- - Results showed that those receiving exenatide had a notable improvement in motor function, with a significant adjusted mean difference compared to the placebo group, indicating potential benefits of exenatide in managing Parkinson's symptoms.
The evolution of dengue viruses has resulted in four antigenically similar yet distinct serotypes. Infection with one serotype likely elicits lifelong immunity to that serotype, but generally not against the other three. Secondary or sequential infections are common, as multiple viral serotypes frequently cocirculate.
View Article and Find Full Text PDF